CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in PCRX — Pacira BioSciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,525,240
+$981,091 QoQ
Shares Held
690,786
-5.6% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. PCRX ranks #19 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,525,240 | 690,786 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,544,149 | 732,042 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,503,989 | 676,352 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,164,825 | 627,273 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,624,888 | 570,079 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,033,477 | 524,486 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $9,461,523 | 502,204 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,500,049 | 431,897 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,875,381 | 415,078 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,101,492 | 414,151 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,540,010 | 371,666 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,043,879 | 359,970 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $13,965,076 | 348,517 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,197,146 | 347,884 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,166,164 | 341,004 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,647,112 | 331,775 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,722,636 | 321,143 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,624,079 | 348,848 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,635,206 | 359,568 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $19,099,360 | 341,060 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,503,644 | 321,418 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $22,120,964 | 315,608 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $20,101,991 | 335,929 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,001,563 | 332,694 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $18,578,735 | 354,083 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $11,423,436 | 340,693 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||